{"id":402972,"date":"2022-02-10T07:21:17","date_gmt":"2022-02-10T10:21:17","guid":{"rendered":"https:\/\/www.ip.gov.py\/ip\/?p=402972"},"modified":"2022-02-10T07:21:17","modified_gmt":"2022-02-10T10:21:17","slug":"pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos","status":"publish","type":"post","link":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/","title":{"rendered":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os"},"content":{"rendered":"<p style=\"text-align: justify;\"><em><strong>Washington.-<\/strong><\/em>Pfizer y su socio BioNTech informaron que comenzaron el pedido formal de solicitarle al regulador sanitario de Estados Unidos el uso de emergencia de su vacuna contra la COVID para ni\u00f1os entre seis meses y cinco a\u00f1os.<!--more--><\/p>\n<p style=\"text-align: justify;\">La solicitud es actualmente para dos dosis de una inyecci\u00f3n de 3 microgramos, que dar\u00e1 a los padres \u00abla oportunidad de comenzar con una serie de vacunaciones contra la COVID-19 para sus ni\u00f1os mientras esperan la posible autorizaci\u00f3n para una tercera dosis\u00bb, dijo el director general de Pfizer, Albert Bourla, en un comunicado.<\/p>\n<p style=\"text-align: justify;\">Si la agencia estadounidense reguladora de medicamentos, la FDA, autoriza el r\u00e9gimen de dos dosis, se convertir\u00e1 en la primera vacuna anticovid disponible para este grupo etario en Estados Unidos.<\/p>\n<p style=\"text-align: justify;\">Poco despu\u00e9s del anuncio, la FDA indic\u00f3 en un tuit que sostendr\u00e1 una reuni\u00f3n el 15 de febrero para considerar el pedido.<\/p>\n<p style=\"text-align: justify;\">Las compa\u00f1\u00edas est\u00e1n buscando la autorizaci\u00f3n para solo dos dosis de su vacuna, pero piensan que una tercera dosis ser\u00e1 necesaria \u00abpara alcanzar altos niveles de protecci\u00f3n contra las actuales y futuras posibles variantes\u00bb del coronavirus, afirm\u00f3 Bourla.<\/p>\n<p style=\"text-align: justify;\">\u00abSi las dos dosis son autorizadas, los padres tendr\u00e1n la oportunidad de comenzar con una serie de vacunaciones contra la COVID-19 para sus ni\u00f1os mientras esperan la posible autorizaci\u00f3n para una tercera dosis\u00bb, agreg\u00f3.<\/p>\n<p style=\"text-align: justify;\">Algunos expertos ya se han pronunciado en contra de esta inusual medida.<\/p>\n<p style=\"text-align: justify;\">No obstante, la jefa interina de la FDA, Janet Woodcock, defendi\u00f3 el martes la necesidad de avanzar r\u00e1pidamente: \u00abTener una vacuna segura y eficaz disponible para los ni\u00f1os de este grupo etario es una prioridad para la agencia\u00bb, declar\u00f3 en un comunicad.<\/p>\n<p style=\"text-align: justify;\">Estados Unidos cuenta con cerca de 23 millones de ni\u00f1os menores de 5 a\u00f1os. Ya con dos a\u00f1os de pandemia, muchos padres esperan impacientes vacunar a sus ni\u00f1os contra el coronavirus.<\/p>\n<p style=\"text-align: justify;\">Pero las autoridades sanitarias est\u00e1n igualmente enfrentadas a un gran escepticismo de parte de otros padres.<\/p>\n<p style=\"text-align: justify;\">Las tasas de vacunaci\u00f3n son mucho menores entre ni\u00f1os. La vacuna est\u00e1 disponible desde hace tres meses en Estados Unidos para ni\u00f1os entre 5 y 11 a\u00f1os, pero hasta el momento solo 30% de ellos han recibido al menos una dosis, y alrededor de 22% est\u00e1n completamente vacunados, seg\u00fan los Centros para el Control y la Prevenci\u00f3n de Enfermedades (CDC).<\/p>\n<p style=\"text-align: justify;\">Los ni\u00f1os son menos susceptibles a caer gravemente enfermos por la COVID-19, pero algunos terminan hospitalizados.<\/p>\n<p style=\"text-align: justify;\">Debido al elevado n\u00famero de infecciones, el brote de la variante \u00f3micron ha enviado a un n\u00famero r\u00e9cord de ni\u00f1os al hospital. Los ni\u00f1os peque\u00f1os tambi\u00e9n pueden desarrollar casos graves de s\u00edndrome inflamatorio multisist\u00e9mico pedi\u00e1trico (MIS-C).<\/p>\n<p style=\"text-align: justify;\">Unos 400 ni\u00f1os de entre 0 y 4 a\u00f1os han muerto de covid-19 en Estados Unidos desde el inicio de la pandemia, seg\u00fan las cifras de los CDC.Clarin.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>Washington.-Pfizer y su socio BioNTech informaron que comenzaron el pedido formal de solicitarle al regulador sanitario de Estados Unidos el uso de emergencia de su vacuna contra la COVID para ni\u00f1os entre seis meses y cinco a\u00f1os.<\/p>\n","protected":false},"author":11,"featured_media":402978,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[5],"tags":[2578,10608,5459,3425,3120],"class_list":{"0":"post-402972","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-internacionales","8":"tag-aprobacion","9":"tag-fda","10":"tag-pedido","11":"tag-pfizer","12":"tag-vacuna"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.\" \/>\n<meta property=\"og:description\" content=\"Washington.-Pfizer y su socio BioNTech informaron que comenzaron el pedido formal de solicitarle al regulador sanitario de Estados Unidos el uso de emergencia de su vacuna contra la COVID para ni\u00f1os entre seis meses y cinco a\u00f1os.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/\" \/>\n<meta property=\"og:site_name\" content=\".::Agencia IP::.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPParaguay\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-10T10:21:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1120\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"vrios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:site\" content=\"@IPParaguay\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"vrios\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/\"},\"author\":{\"name\":\"vrios\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\"},\"headline\":\"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os\",\"datePublished\":\"2022-02-10T10:21:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/\"},\"wordCount\":508,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Vacuna.png\",\"keywords\":[\"Aprobaci\u00f3n\",\"FDA\",\"Pedido\",\"Pfizer\",\"vacuna\"],\"articleSection\":[\"Internacionales\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/\",\"name\":\"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Vacuna.png\",\"datePublished\":\"2022-02-10T10:21:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Vacuna.png\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/Vacuna.png\",\"width\":1120,\"height\":630,\"caption\":\"El Economista\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/2022\\\/02\\\/10\\\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#website\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"name\":\".::Agencia IP::.\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#organization\",\"name\":\"Agencia IP\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/wp-content\\\/uploads\\\/2018\\\/01\\\/Agencia-IP.jpg\",\"width\":150,\"height\":150,\"caption\":\"Agencia IP\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPParaguay\\\/\",\"https:\\\/\\\/x.com\\\/IPParaguay\",\"https:\\\/\\\/www.instagram.com\\\/IPParaguay\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/#\\\/schema\\\/person\\\/fa3668852e893cb0423795330f919039\",\"name\":\"vrios\",\"url\":\"https:\\\/\\\/www.ip.gov.py\\\/ip\\\/author\\\/vrios\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/","og_locale":"es_ES","og_type":"article","og_title":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.","og_description":"Washington.-Pfizer y su socio BioNTech informaron que comenzaron el pedido formal de solicitarle al regulador sanitario de Estados Unidos el uso de emergencia de su vacuna contra la COVID para ni\u00f1os entre seis meses y cinco a\u00f1os.","og_url":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/","og_site_name":".::Agencia IP::.","article_publisher":"https:\/\/www.facebook.com\/IPParaguay\/","article_published_time":"2022-02-10T10:21:17+00:00","og_image":[{"width":1120,"height":630,"url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png","type":"image\/png"}],"author":"vrios","twitter_card":"summary_large_image","twitter_creator":"@IPParaguay","twitter_site":"@IPParaguay","twitter_misc":{"Escrito por":"vrios","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#article","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/"},"author":{"name":"vrios","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039"},"headline":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os","datePublished":"2022-02-10T10:21:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/"},"wordCount":508,"publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png","keywords":["Aprobaci\u00f3n","FDA","Pedido","Pfizer","vacuna"],"articleSection":["Internacionales"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/","url":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/","name":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os - .::Agencia IP::.","isPartOf":{"@id":"https:\/\/www.ip.gov.py\/ip\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#primaryimage"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png","datePublished":"2022-02-10T10:21:17+00:00","breadcrumb":{"@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#primaryimage","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2022\/02\/Vacuna.png","width":1120,"height":630,"caption":"El Economista"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ip.gov.py\/ip\/2022\/02\/10\/pfizer-pidio-la-aprobacion-de-su-vacuna-contra-la-covid-para-ninos-menores-de-5-anos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ip.gov.py\/ip\/"},{"@type":"ListItem","position":2,"name":"Pfizer pidi\u00f3 la aprobaci\u00f3n de su vacuna contra la covid para ni\u00f1os menores de 5 a\u00f1os"}]},{"@type":"WebSite","@id":"https:\/\/www.ip.gov.py\/ip\/#website","url":"https:\/\/www.ip.gov.py\/ip\/","name":".::Agencia IP::.","description":"","publisher":{"@id":"https:\/\/www.ip.gov.py\/ip\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ip.gov.py\/ip\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.ip.gov.py\/ip\/#organization","name":"Agencia IP","url":"https:\/\/www.ip.gov.py\/ip\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/","url":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","contentUrl":"https:\/\/www.ip.gov.py\/ip\/wp-content\/uploads\/2018\/01\/Agencia-IP.jpg","width":150,"height":150,"caption":"Agencia IP"},"image":{"@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPParaguay\/","https:\/\/x.com\/IPParaguay","https:\/\/www.instagram.com\/IPParaguay"]},{"@type":"Person","@id":"https:\/\/www.ip.gov.py\/ip\/#\/schema\/person\/fa3668852e893cb0423795330f919039","name":"vrios","url":"https:\/\/www.ip.gov.py\/ip\/author\/vrios\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/402972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/comments?post=402972"}],"version-history":[{"count":0,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/posts\/402972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media\/402978"}],"wp:attachment":[{"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/media?parent=402972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/categories?post=402972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ip.gov.py\/ip\/wp-json\/wp\/v2\/tags?post=402972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}